Published in Drug Week, April 2nd, 2004
According to recent research from Argentina, "Highly active antiretroviral therapy has resulted in a dramatic decline in morbidity and mortality among patients infected with HIV. Nevertheless, this success has to be considered in the context of the current challenges and needs in this field. Adherence, toxicity, potency, and resistance are still matters of intense research, which need to improve in order to overcome the current limitations of available drugs."
"Regarding needs, the improvement of convenience, tolerability, and pharmacokinetics run in parallel with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.